| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $91.7M | +9.3% |
| Cost of Revenue | $18.1M | +72.7% |
| Gross Profit | $73.6M | +0.3% |
| R&D Expense | $2.6M | +6.0% |
| SG&A Expense | $18.9M | +4.8% |
| Operating Income | $6.9M | -62.7% |
| Pre-tax Income | $7.7M | -59.9% |
| Income Tax | $2.7M | -50.4% |
| Net Income | $4.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.0M | -41.4% |
| Accounts Receivable | $10.7M | -16.4% |
| Inventory | $124K | — |
| Current Assets | $23.4M | -26.4% |
| Total Assets | $45.2M | -17.4% |
| Current Liabilities | $34.2M | -6.4% |
| Total Liabilities | $47.6M | -5.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.7M | -73.2% |
| Capital Expenditures | $65K | -63.3% |
| Investing Cash Flow | -$65K | +63.3% |
| Financing Cash Flow | -$13.1M | +31.1% |
| Free Cash Flow | $5.6M | -73.3% |
| -65.4% |
| EPS (Basic) | $0.42 | -61.1% |
| EPS (Diluted) | $0.41 | -61.3% |
| Stockholders' Equity |
| -$7.5M |
| -1526.8% |